Luteal angiogenesis: Prevention and intervention by treatment with vascular endothelial growth factor trapA4o

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3377-3386

  Wulff, Christine ^a   Wilson, Helen ^a   Rudge, John S ^b   Wiegand, Stanley J ^b   Lunn, Stephen F ^a   Fraser, Hamish M ^a  

^a MRC Reproductive Biology Unit   (United Kingdom)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BROXURIDINE; PROGESTERONE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR TRAP; VASCULOTROPIN;

ADOLESCENT; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS LUTEUM; CORPUS LUTEUM FUNCTION; DRUG ACTIVITY; ENDOTHELIUM CELL; FEMALE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL;

ANGIOPOIETIN-2; ANIMALS; ANTIGENS, CD31; BROMODEOXYURIDINE; CALLITHRIX; CELL DIVISION; CORPUS LUTEUM; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOGLOBULIN FC FRAGMENTS; IN SITU HYBRIDIZATION; LUTEAL PHASE; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SIZE; OVARY; OVULATION; PROGESTERONE; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034920084     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.3377     Document Type: Article

References (34)

1. Angiogenesis in cancer and other diseases
2. Rote of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome
3. Angiogenesis and its control in the female reproductive system
4. Angiogenesis in endometriosis
5. Angiogenic activity of peritoneal fluid from women with endometriosis
6. Angiogenesis in endometriosis and angiogenic factors
7. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization
8. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
9. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum
10. Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate
11. Suppression of luteal angiogenesis in the primate by neutralization of vascular endothelial growth factor
12. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
13. Increased vascularization in mice overexpressing angiopoietin-1
14. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
15. Angiopoietein-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
16. Angiogenesis in the human corpus luteum: Localization and changes in angiopoietins, Tie-2 and vascular endothelial growth factor messenger ribonucleic acid
17. The effects of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate
18. Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus)
19. Inhibin secretion during the ovulatory cycle and pregnancy in the common marmoset monkey
20. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
21. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
22. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary
23. Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia
24. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: Potential relevance to menstruation and endometrial regeneration
25. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (P1GF) and soluble Flt-1 by oxygen - A review
26. Regulation of angiogenesis by hypoxic stress: From solid tumours to the ovarian follicle
27. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction
28. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells
29. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro
30. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
31. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion
32. Expression of angiopoietin-2 by human endometrial endothelial cells: Regulation by hypoxia and inflammation
33. Cooperative roles for the angiopoietins and vascular endothelial growth factor in ovarian angiogenesis
34. Signaling vascular morphogenesis and maintenance